Medica RCP |Venclexta 10mg | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Venclexta 10mg

Contraindicated
Embryotoxic and foetotoxic in animals

Contraindicated

Venclexta 10mg :
Type	Medicine Authorised
Originator	B
Agent	Interpharma
Distributor	Interpharma
Laboratory	AbbVie
Responsible Party	Abbvie Inc
Origin	U.S.A.
Manufacturer	Abbvie Inc
Origin	U.S.A.
ATC	L01XX52

Venclexta 10mg :

Oral

Venclexta 10mg :

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01X Other antineoplastic agents

L01XX Other antineoplastic agents

L01XX52 Venetoclax

Venclexta 10mg :

Venetoclax : 10mg

Venclexta 10mg :

Adults : Chronic lymphocytic leukemia in the absence of 17p deletion or TP53 mutation in patients who have failed both chemoimmunotherapy and a B cell receptor pathway inhibitor 50mg/day for 1 week

Adults : Chronic lymphocytic leukemia in the presence of 17p deletion or TP53 mutation in patients who are unsuitable for or have failed a B cell receptor pathway inhibitor 50mg/day for 1 week

Venclexta 10mg :

Revision Date : 31/08/2018

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Anaemia	Very Common
Blood creatinine increased	Common
Constipation	Very Common
Diarrhoea (Diarrhea)	Very Common
Fatigue	Very Common
Febrile neutropenia (Neutropenic fever)	Common
Hyperkalaemia	Common
Hyperphosphataemia	Very Common
Hyperuricaemia	Common
Hypocalcaemia	Common
Lymphopenia	Common
Nausea	Very Common
Neutropenia	Very Common
Pneumonia	Common
Septicemia	Common
Tumour lysis syndrome	Common
Upper respiratory tract infection	Very Common
Urinary tract infection	Common
Vomiting	Very Common

Venclexta 10mg :

Abu Dhabi

Bahrain

Belgium

Cyprus

Denmark

Finland

France

Germany

Greece

Ireland

Italy

KSA

Lebanon

New Zealand

Norway

Qatar

Spain

Sweden

Switzerland

The Netherlands

Turkey

UAE

Medicine Authorised

Venclexta 100mg

Interpharma

AbbVie

Medicine Authorised

Venclexta 50mg

Interpharma

AbbVie

Medicine Authorised

Venclexta Starting Pack

Interpharma

AbbVie

NB : Products With Same Indication

Coming Very Soon

Venclexta 10mg
MoH 9153

Different Units By MoH Code

Venclexta 10mg MoH 9153 :

Form Tablet

Packaging Blisters

Package Size Box of 14

Strength 10mg

Public Price 12966029.68 L.L.

Stratum C

NSSF ✔

Quarantine ✘

Reg. Number 54917/1

Submission date 01/01/2017

Registration Year 2017

Price Comparison

You have to register to view this info

Note

You have to register to view this info

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Tablet
Packaging	Blisters
Package Size	Box of 14
Strength	10mg
Public Price	12966029.68 L.L.
Stratum	C
NSSF	✔
Quarantine	✘
Reg. Number	54917/1
Submission date	01/01/2017
Registration Year	2017